San Francisco's science and engineering industry is on a roll with investors, with 10 local companies securing venture capital. New funding rounds were recently announced by science and engineering ventures Bigfinite, Shasqi and Kover.ai, according to company database Crunchbase.
Bigfinite topped the city's recent funding headlines by announcing a $15 million Series B round on Nov. 4, led by Honeywell Venture Capital.
According to its Crunchbase profile, "Bigfinite is a cloud-based SaaS platform that helps optimize industrial processes in biotech and pharma, covering all the supply chain, from R+D to patient dispensing."
The six-year-old company has raised three previous funding rounds, including a $8.5 million seed round in 2017.
Next up, Shasqi raised $10 million in Series A funding, in a round announced on Oct. 31 and financed by Y Combinator.
According to Crunchbase, "Shasqi develops cancer treatment intended to use bio-orthogonal chemistry for localized drug delivery. Its treatment permits delivery of more than one drug to the tumor with fewer side effects, enabling physicians to treat their patients in an enhanced way."
The company also raised a $120,000 seed round in 2015.
Meanwhile, Kover.ai raised $1.5 million in seed funding, announced on Nov. 4. The round's investors were led by West Loop Ventures.
From the company's Crunchbase profile: "Kover.ai leverages decentralized software to enable any business to build and distribute coverage products to its own customers through an API, bypassing the need to involve any insurance company. Provider of smart contracts intended to create autonomous insurances that run with near-zero overhead."
Kover.ai last raised $120,000 in pre-seed funding earlier this year.
Overall, San Francisco-based science and engineering companies have raised $133 million in venture funding over the past month, and $7.9 billion over the past year.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
